Darleshia Bibbins, LCSW | |
4315 Bluebonnet Blvd, Baton Rouge, LOUISIANA 70809 | |
(225) 223-6968 | |
Not Available |
Full Name | Darleshia Bibbins |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 4315 Bluebonnet Blvd, Baton Rouge, LOUISIANA |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477083202 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Darleshia Bibbins, LCSW 4315 Bluebonnet Blvd, Baton Rouge, LOUISIANA 70809 Ph: () - | Darleshia Bibbins, LCSW 4315 Bluebonnet Blvd, Baton Rouge, LOUISIANA 70809 Ph: (225) 223-6968 |
News Archive
VIVUS, Inc. today announced that it has terminated the Development and Commercialization Agreement with FemPharm Pty Ltd. (a wholly owned subsidiary of Acrux Limited) for Luramistâ„¢, a metered dose transdermal application of testosterone for women.
Glaucoma affects millions of Americans. Common treatments, although highly effective, remain invasive and prone to complications.
Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis, it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.
For children with severe traumatic brain injury (TBI), transplantation of stem cells derived from the patients' own bone marrow is a "logistically feasible and safe" treatment procedure, reports the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Pharmaceutical ads marketed directly to the consumer may minimize the risks and exaggerate the benefits of medications, often confusing the public about what drugs are most effective, but Dartmouth Medical School (DMS) researchers have found a remedy.
› Verified 1 days ago